Member contributed global industry news, new member announcements, articles & opinion.
Join our IP experts Bregt Raus and Bart Bollen for our IP Update on Thursday 30 March from 13:30 – 14:30. In this webinar, they will share with you the traps and mistakes that companies make when licensing their intellectual property. Learn how to identify and address key issues in licensing agreements to avoid legal […]
Some of us underestimate the potential and power that social media has, which automatically means that it has its own set of pros and cons. The undeniable fact is that there needs to be some standard of control placed on such platforms to prevent miscreants from converting the positive feature of freedom and autonomy offered […]
Introduction With war waging in Ukraine, immense pain and suffering has been inflicted upon the Ukrainian population. Those who could (and wanted) left in the face of the Russian aggression, generating the largest influx of refugees in recent European history. Neighbouring countries, such as Romania, Poland and Republic of Moldova, had to adapt almost overnight […]
March Visa Bulletin Includes Updates on Visa Availability in Coming Months
The Department of State’s Visa Bulletin for March 2023 includes updates on visa availability in various categories, including possible retrogressions in the coming months: Visa availability in the EB-2 preference category for all countries (including China and India): Higher than expected number use, mostly due to continued new filings by applicants from all countries with […]
As we approach the third anniversary of our first Covid lockdown, Wednesday, 17 March, saw Chancellor Jeremy Hunt rise to the Despatch Box to deliver the first Full Budget in 504 days. The Spring Budget 2023 is the first unaffected by the immediate impact of the pandemic since October 2018. Over the past few years, […]
ChatGPT is an AI tool that has come to be immensely popular recently as well as a hot topic among lawyers. This and similar systems are quickly becoming commonplace in commercial practice, and this has also given rise to grave legal concerns and risks. Even at the moment, the risk connected with using such tools […]
National Court Partially Accepts Universal Pictures International Spain’s Appeal Against Tax Assessment on Transfer Pricing Methodology The National Court in Spain has partially accepted the appeal made by Universal Pictures International Spain SL against a tax assessment made by the Spanish tax authority regarding its transfer pricing methodology. Universal Group’s business activities included the marketing […]
Recreational Windfall: How to Prepare for Outside Players in Montana’s Cannabis Industry Join national cannabis service providers Clark Hill, MGO, and eXp Commercial for a deep dive into the challenges and opportunities facing operators in Montana’s new adult-use cannabis industry. With moderation by Clark Hill cannabis attorney Bob Hoban, this webinar will feature cannabis […]
Secure your Early Bird ticket for our Annual Conference in Amsterdam!
We’re already mid-way through March and our first conference of the year has just wrapped up in Bangkok, so why not think ahead to our Annual Conference in September? There is just over one week left to benefit from our Early Bird ticket price, giving members 10% off the original ticket price, only available in […]
As April looms and previously announced tax increases come into effect, you could be forgiven for thinking as a business owner that the UK Government is working to an anti-business agenda.Has today’s Spring Budget gone some way to correct this, by encouraging entrepreneurship, business investment and a pro-business agenda? Our Budget Summary highlights the main […]
Author: Salvatore Tramontano The civil liability for damages underlying the risks, multiple and often unpredictable, linked to the delicacy of the medical-professional activity, has now made it clear to the healthcare professional the need to identify new means of asset protection, possibly complementary and reinforcing with respect to the traditional instrument of the insurance policy, […]
Artificial Intelligence and the Implications for Drug Manufacturers (FDA Discussion)
On March 1, 2023, the FDA’s Center for Drug Evaluation and Research (CDER) issued a discussion paper on the role of Artificial Intelligence (AI) in the context of drug manufacturing and the implications for “measurement, modeling, and control technologies used in pharmaceutical manufacturing” (FDA, 2023). The discussion paper referenced Current Good Manufacturing Practice(s) (CGMP) regulations […]
